Popular Articles

Diagnostics Waiting Times & Activity Data: Month Ending March 2009
This data shows the NHS" progress in tackling the waiting times for

Hitting Cell Hot Spot Could Help Thwart Parkinson's Disease
The latest work to "turn off the taps" in the brain and stop a chemical being released in excess amounts which can lead to Parkinson"s Disease - was presented at The British Pharmacological Society"s Summer Meeting in Edinburgh.
News of the day
Eupean Action Against Rare Cancers
European Action Against Rare Cancers is a new campaign that has been launched today to coincide with the publication of the European Commission"s Communication on Cancer. The new campaign urges European policy-makers to prioritise better treatment and care for patients with rare cancers within the framework of the new Commission Communication on cancer and other recent policy initiatives such as the Council Recommendation on Rare Diseases.
Sexual Health

Upcoming BioAlliance Pharma's Presentations At International Conferences On Infectious Diseases And Oncology

BioAlliance Pharma SA (Paris:BIO), a company dedicated to therapies and supportive care for cancer and AIDS patients, announced its scientific communications at upcoming international conferences on infectious diseases and oncology: Loramyc®, indicated for fungal infections in immune-compromised patients with HIV or cancer The 2009 American Society of Clinical Oncology (ASCO) Annual Meeting May 29 to June 2, 2009 - Orlando, Florida, USA. Abstract: "Prevalence and management of oropharyngeal candidiasis (OPC) by medical and radiation oncologists in cancer patients". At the American Conference for the Treatment of HIV (ACTHIV) that took place on May 15-17, 2009 in Denver, Colorado, USA, BioAlliance Pharma presented the poster: "Once-Daily Miconazole Mucoadhesive Buccal Tablet is an Effective and Safe Treatment for Oropharyngeal Candidiasis". Amep™, a biotherapy for Metastatic Melanoma treatment American Society of Gene Therapy (ASGT) 12th Annual Meeting May 27-30, 2009 - San Diego, California, USA Poster: "Complete Melanoma Regressions after Electrotransfer of the p-AMEP™ Plasmid Coding for an Anti-Angiogenic and Anti-Metastatic Peptide", May 28. Anti-integrases: new antiretroviral drugs for the treatment of resistant HIV-1 XVIII International HIV Drug Resistance Workshop June 9-13, 2009 - Fort Myers, Florida, USA Oral communication and poster: "New integrase binding inhibitors acting in synergy with Raltegravir", June 12. Irinotecan SRN oral formulation for the treatment of advanced colorectal cancer 2nd Pharmaceutical Sciences Fair and Exhibition (PharmSciFair) June 8-12, 2009, Nice, France Oral communication: "Sustained Release Nanoparticles (SRN) for oral administration of Irinotecan", June 10. BioAlliance Pharma


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):